Medication Guide App

TEVA 7334 (Mycophenolate mofetil 250 mg)

Pill imprint TEVA 7334 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; organ transplant, rejection prophylaxis; myasthenia gravis; pulmonary fibrosis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for TEVA 7334 (Mycophenolate mofetil 250 mg)

Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil 250 mg TEVA 7334
Mycophenolate mofetil
Imprint:
TEVA
7334
Strength:
250 mg
Color:
Blue & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7334

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)